logo

For the Inventor, By the Inventor

Durham, NC, United States of America

Ann Marie Pendergast

This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignees: Duke University, New York University, Sugen Incorporated. Active years: 1999-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ann Marie Pendergast. Retrieved from https://idiyas.com/inventor/ann-marie-pendergast

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0

Average Co-Inventor Count = 1.9

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal5 out of 2,085 
 
Duke University
 patents
silverMedal1 out of 1,729 
 
New York University
 patents
bronzeMedal1 out of 157 
 
Sugen Incorporated
 patents
4. 2 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...
7 patents (USPTO):Explore Patents
1. 12419891 - Compositions for the treatment of pathogenic- and/or chemical-induced lung injury and for the treatment of cancer and methods of using same (2025-09-23),
2. 11883401 - Compositions for the treatment of pathogenic- and/or chemical-induced lung injury and for the treatment of cancer and methods of using same (2024-01-30),
3. 9931342 - Compositions and methods for the treatment of cancer (2018-04-03),
4. 7384907 - Method of treating infection with ABl tyrosine kinase inhibitors (2008-06-10),
5. 6528270 - Methods for identifying compounds for treatment of cell proliferative disorders associated with adaptor protein interactions (2003-03-04),
6. 6066463 - Method and compositions for treatment of BCR-ABL associated leukemias (2000-05-23),
7. 5969101 - ABL-interactor protein (1999-10-19),

Title: Ann Marie Pendergast: Innovator in Lung Injury and Cancer Treatment

Introduction

Ann Marie Pendergast is a distinguished inventor based in Durham, NC, known for her significant contributions to the fields of lung injury treatment and cancer therapies. With a total of seven patents to her name, she has made remarkable strides in developing innovative solutions for serious health conditions.

Latest Patents

Her latest patents focus on compositions for the treatment of pathogenic- and/or chemical-induced lung injury and cancer. These patents provide methods for regenerating lung epithelial cells following injury and for sensitizing cancer patients to chemotherapeutic agents. The innovative approaches outlined in her patents aim to improve patient outcomes and enhance the effectiveness of existing treatments.

Career Highlights

Throughout her career, Ann Marie has worked with reputable institutions, including Duke University. Her work has been instrumental in advancing medical research and developing new therapeutic strategies.

Collaborations

She has collaborated with notable colleagues such as Aaditya Khatri and Joseph Schlessinger, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Ann Marie Pendergast's work exemplifies the impact of innovation in medicine, particularly in addressing complex health challenges like lung injury and cancer. Her contributions continue to inspire advancements in therapeutic approaches and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…